Perricone, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 4.259
AS - Asia 4.132
EU - Europa 2.586
SA - Sud America 1.224
AF - Africa 93
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.305
Nazione #
US - Stati Uniti d'America 4.147
SG - Singapore 2.303
BR - Brasile 1.048
IE - Irlanda 1.042
IT - Italia 548
CN - Cina 528
HK - Hong Kong 515
RU - Federazione Russa 454
VN - Vietnam 386
DE - Germania 128
KR - Corea 117
GB - Regno Unito 82
SE - Svezia 77
AR - Argentina 63
FI - Finlandia 63
CA - Canada 48
ID - Indonesia 44
FR - Francia 39
IN - India 38
BD - Bangladesh 36
MX - Messico 35
ZA - Sudafrica 35
EC - Ecuador 34
JP - Giappone 30
UA - Ucraina 30
PL - Polonia 24
CO - Colombia 23
IQ - Iraq 23
TR - Turchia 22
NL - Olanda 21
UZ - Uzbekistan 20
PY - Paraguay 19
ES - Italia 18
AT - Austria 16
EG - Egitto 13
MA - Marocco 13
PE - Perù 10
VE - Venezuela 10
SA - Arabia Saudita 9
CH - Svizzera 8
JO - Giordania 7
PK - Pakistan 7
CL - Cile 6
PA - Panama 6
TN - Tunisia 6
BO - Bolivia 5
GR - Grecia 5
IL - Israele 5
LB - Libano 5
NP - Nepal 5
SN - Senegal 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
AZ - Azerbaigian 4
BE - Belgio 4
DZ - Algeria 4
JM - Giamaica 4
MY - Malesia 4
PT - Portogallo 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
HN - Honduras 3
KZ - Kazakistan 3
RO - Romania 3
SV - El Salvador 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
BG - Bulgaria 2
BH - Bahrain 2
CG - Congo 2
CI - Costa d'Avorio 2
DK - Danimarca 2
HU - Ungheria 2
KE - Kenya 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
ML - Mali 2
NG - Nigeria 2
OM - Oman 2
TW - Taiwan 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
CV - Capo Verde 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GN - Guinea 1
GP - Guadalupe 1
GY - Guiana 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
Totale 12.290
Città #
Singapore 1.427
Dublin 1.037
Hong Kong 514
Chandler 402
Santa Clara 345
Boardman 330
Altamura 321
Moscow 286
Medford 280
Princeton 278
Lawrence 225
Ashburn 203
Los Angeles 198
Dong Ket 143
Columbus 122
San Mateo 120
Seoul 115
São Paulo 96
Andover 95
Ho Chi Minh City 79
New York 67
The Dalles 67
Wilmington 67
Perugia 55
Hanoi 51
Helsinki 49
Beijing 48
Dallas 46
Piscataway 39
San Paolo di Civitate 37
Falls Church 33
Munich 31
Rio de Janeiro 30
Tokyo 25
Belo Horizonte 24
Guangzhou 23
Brooklyn 22
Nuremberg 22
Warsaw 22
Brasília 21
Montreal 21
Johannesburg 20
Shanghai 19
Chicago 18
Des Moines 18
Norwalk 18
Bolzano 17
Porto Alegre 17
Redmond 17
San Francisco 17
Hefei 16
Boston 15
Curitiba 15
Tashkent 15
Campinas 14
Da Nang 14
Guayaquil 14
Bologna 13
Houston 13
Magelang 13
Phoenix 13
Salvador 13
Atlanta 12
Denver 12
Jakarta 12
Quito 12
Stockholm 12
Baghdad 11
Biên Hòa 11
London 11
Manchester 11
Rome 11
Toronto 11
Buenos Aires 10
Chennai 10
Goiânia 10
Asunción 9
Charlotte 9
Frankfurt am Main 9
Guarulhos 9
Haiphong 9
Lappeenranta 9
Mexico City 9
Amsterdam 8
Aracaju 8
Milan 8
Ribeirão Preto 8
Shenyang 8
São Bernardo do Campo 8
Volta Redonda 8
Zhengzhou 8
Amman 7
Bắc Ninh 7
Duque de Caxias 7
Orem 7
Poplar 7
Saint Petersburg 7
Santo André 7
Araçatuba 6
Changsha 6
Totale 8.089
Nome #
Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort 97
Pregnancy outcome in systemic lupus erythematosus patients: a monocentric cohort analysis 94
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 77
Effectiveness and safety of baricitinib in rheumatoid arthritis: a monocentric, longitudinal, real-life experience 75
Belimumab is Able to Induce a Significant Improvement of Joint Activity Status in Patients Diagnosed with Systemic Lupus Erythematosus: Results From a 12-Month Longitudinal Study 75
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy 73
Correspondence on a € Anti-inflammatory therapy for COVID-19 infection: The case for colchicine' 73
Autoantibodies in inflammatory arthritis 71
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus 71
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 71
Genetic diversity of Staphylococcus aureus influences disease phenotype of systemic lupus erythematosus 71
Intravenous immunoglobulins at the crossroad of autoimmunity and viral infections 71
Altered expression of miR-142, miR-155, miR-499a and of their putative common target MDM2 in systemic lupus erythematosus 71
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 69
Influence of autoimmunity and inflammation on endothelial function and thrombosis in systemic lupus erythematosus patients 67
TNFAIP3 gene polymorphisms in three common autoimmune diseases: Systemic lupus erythematosus, rheumatoid arthritis, and primary sjogren syndrome - association with disease susceptibility and clinical phenotypes in Italian patients 67
A polymorphism upstream MIR1279 gene is associated with pericarditis development in Systemic Lupus Erythematosus and contributes to definition of a genetic risk profile for this complication 67
Salivary Gland Ultrasonography in Sjögren's Syndrome: A European Multicenter Reliability Exercise for the HarmonicSS Project 67
One year in review 2020: comorbidities, diagnosis and treatment of primary Sjögren's syndrome 66
An update on pathogenesis of psoriatic arthritis and potential therapeutic targets 66
Caffeine intake influences disease activity and clinical phenotype in systemic lupus erythematosus patients 66
Microbiota and arthritis: cause or consequence? 65
Tackling the autoimmune side in Spondyloarthritis: A systematic review 65
Jaccoud's arthropathy in systemic lupus erythematosus: clinical, laboratory and ultrasonographic features 64
Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence 64
STAT4, TRAF3IP2, IL10, and HCP5 Polymorphisms in Sjögren's Syndrome: Association with Disease Susceptibility and Clinical Aspects 64
Peripheral Nervous System Involvement in Sjögren’s Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren’s Syndrome 64
Combined semiquantitative nail-enthesis complex ultrasonography and capillaroscopy in psoriasis and psoriatic arthritis 64
The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart 63
Hypertension and SARS-CoV-2 infection: is inflammation the missing link? 63
Antiphospholipid and Antinuclear Antibodies in Young Patients after Myocardial Revascularization Procedures 63
Autoimmune/Inflammatory Syndrome Induced by Adjuvants and Sjogren's Syndrome 63
'Autoimmunity cutting edge at the 21st century. Representation of the 9th international congress of autoimmunity, nice, France 2014' 63
Authors' reply: Human papillomavirus vaccine and primary ovarian failure 63
Vaccines, adjuvants and autoimmunity 63
Joint involvement influences quality of life in systemic lupus erythematosus patients 63
JAK inhibitors and autoimmune rheumatic diseases 62
[Mosaic of Autoimmunity- the Novel Factors of Autoimmune Diseases Revisited] 62
Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future 62
Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases 60
Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome) - An update 60
On chronic fatigue syndrome and nosological categories 60
Usefulness of composite indices in the assessment of joint involvement in systemic lupus erythematosus patients: correlation with ultrasonographic score 59
Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT. 58
Staphylococcus aureus nasal carriage and autoimmune diseases: From pathogenic mechanisms to disease susceptibility and phenotype 58
The facts and fictions of precision medicine in autoimmune diseases: is the machine learning approach the response? 58
The forefront of autoimmunity 57
Immune checkpoint inhibitors-induced autoimmunity: The impact of gender 57
IL-35: a new immunomodulator in autoimmune rheumatic diseases 57
Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment 56
Prolactin and natural killer cells: Evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion 56
Autoimmune/inflammatory syndrome induced by adjuvants - A new diagnostic problem or the solution of a diagnostic riddle 56
Sjögren's syndrome: one year in review 2022 55
Traditional and disease-related non-computed variables affect algorithms for cardiovascular risk estimation in Sjögren's syndrome and rheumatoid arthritis 55
Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica 55
Significance of anti-La/SSB antibodies in primary Sjögren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy 55
War and Peace at the Feto-Placental Front Line: Recurrent Spontaneous Abortion 55
Being a rheumatologist and a patient with a rheumatic disease today: A perspective at the time of COVID-19 54
). MONITORING OF ANTI-TNF RESPONSE TO TREATMENT IN RHEUMATOID ARTHRITIS: A THREE JOINTS SIMPLIFIED ULTRASONOGRAPHIC STUDY 54
Angiogenesis in rheumatoid arthritis: A disease specific process or a common response to chronic inflammation? 54
A 23-Plex Cytokine/Chemokine Analysis Identifies TNFRII, MMP-8, and sIL-1RII as Potential Biomarkers for Systemic Sclerosis 53
Porphyromonas gingivalis and rheumatoid arthritis 53
Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis 53
Diagnostic and clinical significance of Crohn's disease-specific pancreatic anti-GP2 and anti-CUZD1 antibodies 53
Silicone implants and lymphoma: The role of inflammation 53
The 2014 ACR annual meeting: A bird's eye view of autoimmunity in 2015 53
Musculoskeletal ultrasound in monitoring response to apremilast in psoriatic arthritis patients: results from a longitudinal study 53
The autoimmune side of hereditary angioedema: Insights on the pathogenesis 53
Ultrasound scoring systems affect the distribution of sialadenitis scores in Sjögren's syndrome: an inter-system reproducibility study 52
Premature ovarian failure in patients affected by systemic lupus erythematosus: a cross-sectional study 52
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 52
Cardiovascular Involvement in Sjögren's Syndrome 52
Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19 51
ADALIMUMAB AND POLYMYALGIA RHEUMATICA. CLINICAL REMISSION BUT PERSISTING HIGH LEVELS OF ESR: A CONTROVERSY 51
Treatment with Gonadotropin Releasing Hormone Agonists in Systemic Lupus Erythematosus Patients Receiving Cyclophosphamide: A Long-term Follow-up Study 51
Up-regulation of autophagy by etanercept treatment results in TNF-induced apoptosis reduction in EA.hy926 endothelial cell line 51
Ultrasonographic and clinical assessment of peripheral enthesitis in patients with psoriatic arthritis, psoriasis, and fibromyalgia syndrome: The ULISSE study 51
Human leukocyte antigen (Hla) typing study identifies maternal dq2 susceptibility alleles among infertile women: Potential associations with autoimmunity and micronutrients 51
Cardiovascular risk in systemic autoimmune diseases 50
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 50
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 50
Erratum: Corrigendum to “Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects” (Journal of Autoimmunity (2013) 47 (1–16) (S0896841113001364) (10.1016/j.jaut.2013.10.004)) 49
An overview on the genetic of rheumatoid arthritis: A never-ending story 49
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 49
Genetics, Epigenetics, and Gender Impact in Axial-Spondyloarthritis Susceptibility: An Update on Genetic Polymorphisms and Their Sex Related Associations 49
The hepatitis B vaccine and autoimmune/inflammatory syndrome induced by adjuvants: Relationship with Saccharomyces cerevisiae 48
['ASIA' - Autoimmune/inflammatory syndrome induced by adjuvants: even and odd] 48
Complement, infection, and autoimmunity 48
Porphyromonas gingivalis in the tongue biofilm is associated with clinical outcome in rheumatoid arthritis patients 48
Acne indotta da micofenolato mofetile in pazienti affetti da Lupus Eritematoso Sistemico: uno studio retrospettivo 48
Rational approach to the prescription of anti-rheumatic drugs in rheumatoid arthritis: a product leaflet-based strategy in Italy 47
Alteration of Mitochondrial DNA Copy Number and Increased Expression Levels of Mitochondrial Dynamics-Related Genes in Sjögren’s Syndrome 47
Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis 47
Neuropsychiatric manifestations associated with anti-endothelial cell antibodies in systemic lupus erythematosus 47
Pregnancy and autoimmunity: A common problem 47
Myocardial ischaemia, coronary atherosclerosis and pulmonary pressure elevation in antiphospholipid syndrome patients 47
Postural orthostatic tachycardia with chronic fatigue after HPV vaccination as part of the “Autoimmune/auto-inflammatory syndrome induced by adjuvants”: Case report and literature review 47
Innate Immune System at the Maternal–Fetal Interface: Mechanisms of Disease and Targets of Therapy in Pregnancy Syndromes 47
Tietze Syndrome 47
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: A prospective observational multicentre study (MODERATE) 47
Totale 5.848
Categoria #
all - tutte 80.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.292


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021263 0 0 0 0 0 1 4 94 16 1 4 143
2021/20221.070 0 97 1 4 24 13 15 210 11 26 336 333
2022/20232.636 302 599 35 86 136 169 6 60 1.143 4 79 17
2023/2024970 57 97 77 28 15 18 72 8 28 146 235 189
2024/20253.891 41 358 35 106 582 115 152 269 1.088 294 493 358
2025/20263.807 604 452 551 1.001 844 355 0 0 0 0 0 0
Totale 12.680